glp-1 side effects mental health Dr. Angela Fitch on concerns: Data shows patients' moods get better, not worse GLP-1s: Are We Ignoring the

India as an emerging clinical trial hub India is rapidly establishing itself as a key clinical trial hub, with trial share growth (the relative increase in number of trials sponsored by Indian headquartered companies compared to other key markets) up 109% since 2019, albeit from a low base

95% CI, 0.480.58

Given the overlap between HS and metabolic disease, we wanted to investigate whether GLP-1 therapy could improve HS outcomes in a real-world population. Using the TriNetX research network, researchers evaluated the rates of surgical abscess repairs and hospitalizations among 8,542 participants (mean age, 44 years

Variants in GLP1R and GIPR genes, for example, influence baseline receptor sensitivityinformation that should be interpreted with a qualified healthcare provider to support informed decisions about dose escalation strategy and monitoring intensity